Stereotactic Radiotherapy in the Treatment of Lung Metastases from Bone and Soft-tissue Sarcomas

被引：0

作者：

Frakulli, Rezarta ^{[1
]}

Salvi, Fabrizio ^{[2
]}

Balestrini, Damiano ^{[2
]}

Parisi, Alessandro ^{[2
]}

Palombarini, Marcella ^{[3
]}

Cammelli, Silvia ^{[1
]}

Rocca, Michele ^{[4
]}

Salone, Mariacristina ^{[4
]}

Longhi, Alessandra ^{[5
]}

Ferrari, Stefano ^{[5
]}

Morganti, Alessio G. ^{[1
]}

Frezza, Giovanni ^{[2
]}

机构：

[1] Univ Bologna, Dept Expt Diagnost & Specialty Med, Radiat Oncol Ctr, I-40138 Bologna, Italy

[2] Bellaria Hosp, Radiat Oncol Unit, Bologna, Italy

[3] Bellaria Hosp, Med Phys Unit, Bologna, Italy

[4] Rizzoli Orthopaed Inst, Gen & Thorac Surg, Bologna, Italy

[5] Rizzoli Orthopaed Inst, Dept Oncol, Bologna, Italy

来源：

ANTICANCER RESEARCH | 2015年 / 35卷 / 10期

关键词：

SBRT; sarcoma; lung metastases; PULMONARY METASTASES; SBRT;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Background: The purpose of this study was to evaluate local control and toxicity in a group of patients treated with stereotactic body radiotherapy (SBRT) for lung metastases (LM) from bone and soft tissue sarcomas. Patients and Methods: From October 2010 to July 2014, patients with LM from sarcomas not suitable for surgery were treated with daily cone-beam computed tomography-guided SBRT. The dose administered ranged from 30 to 60 Gy in 3-8 fractions. Acute and late toxicity were scored according to Common Terminology Criteria for Adverse Events version 4.0. Results: A total of 24 patients with 68 LM from sarcomas were treated with SBRT. The median follow-up after SBRT was 17 months (range=11-51 months). Two-year actuarial lesion local control and overall survival were 85.9% and 66.4%, respectively. No G3 or greater acute and late toxicities were observed. Conclusion: SBRT is a safe and effective treatment for LM from sarcoma and might be used as an alternative option in patients unfit for surgery.

引用

页码：5581 / 5586

页数：6

共 50 条

[1] Stereotactic radiotherapy (SBRT)in the treatment of lung metastases from bone and soft tissue sarcomas
Salvi, F.
Frakulli, R.
Longhi, A.
Ferrari, S.
Cammelli, S.
Balestrini, D.
Palombarini, M.
Magi, S.
Morganti, A. G.
Frezza, G.
RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S724 - S725
[2] Stereotactic radiotherapy in the treatment of lung metastases from bone and soft tissue sarcomas: Final results
Salvi, F.
Frakulli, R.
Longhi, A.
Ferrari, S.
Cammelli, S.
Fraina, E.
Balestrini, D.
Palombarini, M.
Magi, S.
Macchia, G.
Ferioli, M.
Deodato, F.
Ronchi, L.
Ammendolia, I.
Shukulli, E.
Monari, F.
Cortesi, A.
Mascia, I. V.
Morganti, A. G.
Frezza, G.
EUROPEAN JOURNAL OF CANCER, 2015, 51 : S694 - S694
[3] PERIOPERATIVE RADIOTHERAPY OF SARCOMAS OF SOFT-TISSUE AND BONE
FRANKE, HD
LANGENBECKS ARCHIV FUR CHIRURGIE, 1987, 372 : 315 - 320
[4] TREATMENT OF BONE AND SOFT-TISSUE SARCOMAS
ROUESSE, J
TUBIANAHULIN, M
PRESSE MEDICALE, 1991, 20 (27): : 1249 - 1251
[5] ROLE OF RADIOTHERAPY IN TREATMENT OF SOFT-TISSUE SARCOMAS
DONATI, E
RADIOBIOLOGICA RADIOTERAPIA E FISICA MEDICA, 1973, 25 (02): : 115 - 130
[6] LIVER METASTASES FROM SOFT-TISSUE SARCOMAS
HAFNER, GH
RAO, U
KARAKOUSIS, CP
JOURNAL OF SURGICAL ONCOLOGY, 1995, 58 (01) : 12 - 16
[7] RADIOTHERAPY OF SOFT-TISSUE SARCOMAS
HELLRIEGEL, W
STRAHLENTHERAPIE, 1978, 154 (02) : 75 - 80
[8] RADIOTHERAPY OF SOFT-TISSUE SARCOMAS
FRANKE, HD
LANGENDORFF, G
SCHMIDT, R
BOCKER, W
CHIRURG, 1983, 54 (10): : 652 - 659
[9] RADIOTHERAPY OF SOFT-TISSUE SARCOMAS
DELREGATO, JA
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1963, 185 (03): : 216 - &
[10] RADIOTHERAPY OF SOFT-TISSUE SARCOMAS
SAUER, R
DUNST, J
LANGENBECKS ARCHIV FUR CHIRURGIE, 1990, : 907 - 917

← 1 2 3 4 5 →